Advertisement

Acta Endoscopica

, Volume 13, Issue 4, pp XLIII–XLIX | Cite as

Lu pour vous

  • E. Varlan
  • J. Faivre
  • C. Treille
Article
  • 1 Downloads

Références

  1. 1.
    ANTHONISEN and Coll.—The Clinical Effect of Salazopyrin in Crohn's disease.Scand. J. Gastroent., 1974, 549–554.Google Scholar
  2. 2.
    CHEVREL B. — Traitement des maladies inflammatoires du colon par la Salazopyrine.M.C.D., 1982,11,o 3.Google Scholar
  3. 3.
    CAMPBELL D. — Pharmacia. Internal report.Google Scholar
  4. 4.
    FIASSE R. and Coll. — Maladie de Crohn à localisation colique prédominante.Acta Gastro-Ent. Belgica. Oct. 1980.XLIII.Google Scholar
  5. 5.
    GEFFROY Y., HECKETSWEILER P. — Réflexions sur le traitement de la maladie de Crohn.Arch. F. Med. App. Dig. 75,64, 625–627.Google Scholar
  6. 6.
    GOLDSTEIN F., THORNTON J.J.. — Anti-inflammatory drug treatment of Crohn's disease: a prospective evaluation of 100 consecutively treated patients.J. Clin. Gastroenterol., 1980,2, 77–85.PubMedGoogle Scholar
  7. 7.
    GOLDSTEIN F., THORNTON J.J.. — Objective and subjective improvement with drug treatment in Crohn's disease. Gastroenterol., 1974,66, A-48/702.Google Scholar
  8. 8.
    GRINHOLTZ A., FERRIER J.P. — Traitement médical de la maladie de Crohn par le corticoïdes, la sulfasalazine et l'azathioprine, M.C.D., 1983.Google Scholar
  9. 9.
    HARRIS. — Determination of prostaglandine synthetase activity in rectal biopsy material and its significance in colonic disease.Gut., 1978, 875–877.Google Scholar
  10. 10.
    KLOTZ U. and Coll. — Therapeutic efficacy of sulfasalazine and its metabolites in patients with ulcerative colitis and Crohn's disease.The New England Journal of Medecine. 303, no 26.Google Scholar
  11. 11.
    KORELITZ B. — Current treatment of Crohn's. Current concepts in Gastroenterol., 1981, summer 3–9.Google Scholar
  12. 12.
    KYLE J. — Crohn's disease. William Heinemann Medical books milited, London, 1972.Google Scholar
  13. 13.
    NAVARRO J. and Coll. Traitement de la maladie de Crohn de l'enfant.Nouvelle Presse Médicale, 1978,7,o 3.Google Scholar
  14. 14.
    NUGENT. — Crohn's colitis comes of age.American Journal Gastroenterol., 1975,63, 471–475.Google Scholar
  15. 15.
    PIROTTE J. — Le traitement médicale de la maladie de Crohn.Revue Médicale de Liège, 1976,31,o 2.Google Scholar
  16. 16.
    RIIS P. — A critical survey of controlled studies in the treatment of ulcerative colitis and Crohn's disease.Clinics in Gastroenterol., 1980,9,o 2.Google Scholar
  17. 17.
    Synthèses Thérapeutiques, 1979, no 9. Adis. The national cooperative Crohn's disease study.Gastroenterol., 1979,77, 825–944.Google Scholar
  18. 18.
    URSING B. and Coll. — A comparative study of Metronidazole and Sulfasalazine for active Crohn's disease. The cooperative Crohn's disease study in Sweden. I-Design and methodologic considerations.Gastroenterol., 1982,83, 541–549. II-Result.Gastroenterol., 1982,83, 550–562.Google Scholar
  19. 19.
    VAN HEES and Coll — Effect of sulphasalazine in patients with active Crohn's disease = a controlled double blind study.Gut, 1981,22, 404–409.PubMedCrossRefGoogle Scholar
  20. 20.
    WENCKERT and Coll. — Long term prophylactic effect of S.A.S.P. in primarily resect patients with Crohn's disease.Scand. J. Gastroenterol., 1978,13, 161–167.PubMedCrossRefGoogle Scholar

Références

  1. 1.
    BRALOW S.P. — Colorectal cancer screening program in Sarasota, Florida. International Symposium on colorectal cancer New York, 6–7 mars 1979.Google Scholar
  2. 2.
    HERZOG P., HOLTERMULLER K.M., PREISS J., FISCHER J., EWE K., SCHREIBER H.J., BERRES M. — Fecal blood loss in patients with colonic polyps: a comparison with the Haemoccult test.Gastroenterology, 1982,83, 957–962.PubMedGoogle Scholar
  3. 3.
    MACRAE F.A., St-JOHN D.J.B.. — Relationships between patterns of bleeding and Hemoccult sensitivity in patients with colorectal cancers and adenomas.Gastroenterology, 1982,82, 891–898.PubMedGoogle Scholar
  4. 4.
    MUTO T., BUSSEY H., MORSON B.C.. — The evolution of cancer of the colon and rectum.Cancer, 1975,36, 2251–2270.PubMedCrossRefGoogle Scholar
  5. 5.
    Van Denbroucke A., Bourdon Ch., Delfosse M., Maisin H. — Prévention et dépistage précoce du cancer restocolique: intérêt du test Hémoccult,Bull. Cancer, 1983, 198–199.Google Scholar

Références

  1. 1.
    OTTENJANN R., ELSTER K. et Coll. — Atlas of diseases of the upper gastrointestinal tract, Vol.III, 302–305. Smith Kline and French Corporation, 1980.Google Scholar
  2. 2.
    TREILLE C., TREILLE GENUER F. COMPAIN P.. — L'Hétérotopie gastrique du duodénum. Une entité méconnue mais fréquente. Intérêt des colorants de muqueuse.Acta endoscopica, 1983,13, 3, 167–175.CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 1983

Authors and Affiliations

  • E. Varlan
    • 1
  • J. Faivre
    • 2
  • C. Treille
  1. 1.Paris
  2. 2.Dijon

Personalised recommendations